BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32847617)

  • 1. Unraveling the complexity: A comprehensive analysis of the PP2A in cancer and its potential for novel targeted therapies.
    Ivovič D; Kabelíková P; Jurkovičová D
    Neoplasma; 2023 Aug; 70(4):485-499. PubMed ID: 37789785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.
    Qi Y; Li L; Wei Y; Ma F
    Biomed Pharmacother; 2024 Apr; 173():116398. PubMed ID: 38458011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIRP Sensitizes Cancer Cell Responses to Ionizing Radiation.
    Sun W; Bergmeier AP; Liao Y; Wu S; Tong L
    Radiat Res; 2021 Jan; 195(1):93-100. PubMed ID: 33429432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome profiling of cells exposed to particular and intense electromagnetic radiation emitted by the "SG-III" prototype laser facility.
    Wei J; Shi Q; Xiong L; Xin G; Yi T; Xiao Y; Huang W
    Sci Rep; 2021 Jan; 11(1):2017. PubMed ID: 33479397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical activation of oncogenic signaling as a cancer treatment strategy.
    Dias MH; Friskes A; Wang S; Fernandes Neto JM; van Gemert F; Mourragui S; Papagianni C; Kuiken HJ; Mainardi S; Alvarez-Villanueva D; Lieftink C; Morris B; Dekker A; van Dijk E; Wilms LHS; da Silva MS; Jansen RA; Mulero-Sanchez A; Malzer E; Vidal A; Santos C; Salazar R; Wailemann RAM; Torres TEP; De Conti G; Raaijmakers JA; Snaebjornsson P; Yuan S; Qin W; Kovach JS; Armelin HA; Te Riele H; van Oudernaarden A; Jin H; Beijersbergen RL; Villanueva A; Medema RH; Bernards R
    Cancer Discov; 2024 Mar; ():. PubMed ID: 38533987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.
    Cucinotta L; Filippone A; Casili G; Lanza M; Bova V; Capra AP; Giuffrida R; Colarossi C; Sciacca D; Paterniti I; Cuzzocrea S; Campolo M; Esposito E
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma
    Kashani E; Vassella E
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 Facilitates DNA Damage-Induced Apoptosis by Interacting With PP2A.
    Yan Q; Zhang B; Ling X; Zhu B; Mei S; Yang H; Zhang D; Huo J; Zhao Z
    Front Cell Dev Biol; 2022; 10():728771. PubMed ID: 35281086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese.
    Wang Y; Huang Q; Huang X; Zhao H; Guan B; Ban K; Zhu X; Ma Z; Tang Y; Su Z; Nong Q
    Pharmgenomics Pers Med; 2021; 14():1565-1574. PubMed ID: 34898995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair.
    Wei D; Parsels LA; Karnak D; Davis MA; Parsels JD; Marsh AC; Zhao L; Maybaum J; Lawrence TS; Sun Y; Morgan MA
    Clin Cancer Res; 2013 Aug; 19(16):4422-32. PubMed ID: 23780887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP2A as a master regulator of the cell cycle.
    Wlodarchak N; Xing Y
    Crit Rev Biochem Mol Biol; 2016; 51(3):162-84. PubMed ID: 26906453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP2A and tumor radiotherapy.
    Lei X; Ma N; Du L; Liang Y; Zhang P; Han Y; Qu B
    Hereditas; 2020 Aug; 157(1):36. PubMed ID: 32847617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
    Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
    Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma.
    Gordon IK; Lu J; Graves CA; Huntoon K; Frerich JM; Hanson RH; Wang X; Hong CS; Ho W; Feldman MJ; Ikejiri B; Bisht K; Chen XS; Tandle A; Yang C; Arscott WT; Ye D; Heiss JD; Lonser RR; Camphausen K; Zhuang Z
    Mol Cancer Ther; 2015 Jul; 14(7):1540-1547. PubMed ID: 25939762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic relevance of the protein phosphatase 2A in cancer.
    Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
    Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.